Why I think buying British American Tobacco shares now might be a lucky strike!

The recent decline in the company’s share price follows the disappointing sales forecast announced on Wednesday.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The share price of cigarette producer British American Tobacco (LSE: BATS) fell by about 5% on Wednesday as it announced market share losses. The company, famous for its iconic Lucky Strike and Dunhill brands, is generally gaining market share.

While the market shares of traditional tobacco products are declining worldwide, British American Tobacco’s other activities in reduced-risk products – including heated tobacco and vaping pens – are expected to grow by between 30% and 50%. British American Tobacco also reaffirmed its confidence in the achievement of its annual objectives.

There’s no smoke without fire, right?

Well, not in this case. Okay, the stock price is about 20% lower than a year ago, but during this period we had a market consolidation in the second half of 2018. In fact, the evolution of the share price since the beginning of the year is positive with a gain of 18%.

This outperforms its nearest competitor, Imperial Brands, which also trades on the London Stock Exchange, whose share price has fallen by 16% a year to date. In the US, Philip Morris International grew by 16% over the period, slightly less than BATS.

The good performance of BATs in recent months might be a sign of a recovery, reflecting analysts’ optimistic expectations for the future.

New CEO might find a second wind for the company

Wednesday’s update of the group’s turnover is the first since the appointment of the new CEO Jack Bowles to replace Nicandro Durante who led the transition to vaping products but left the share price down by about 50% over the past two years and has been criticised for his poor communication to investors.

Mr Bowles, formerly the company’s chief operating officer, is a strong supporter of reduced-risk products and wants to “create a stronger and simpler business” in response to shareholder expectations.

My heated view

Analysts expect the company’s strong operational performance to last for the rest of the year, so Wednesday’s decline makes the stock more attractive in my opinion.

With a P/E ratio 11 lower than that of its main competitors, BATS is the best deal among the major tobacco producers (whose P/Es range from 12 to 16). The company also pays the most generous dividend, with a current yield of 7%, compared to an industry average of about 6%.

The recent recovery in the BATS share price is another sign of renewed investor interest that might create buying momentum above current levels.

The diversification, through the acquisition of stakes in companies, of tobacco majors such as Marlboro’s Altria and Imperial Brands into cannabis products provides access to a huge market of $17bn. Analysts anticipate strong growth in pharmaceutical cannabis products that could enable this industry to reach $150bn in annual revenues. I expect such an announcement would drive the BATS share price to sky-high levels.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jean-Philippe has no position in any company listed here. The Motley Fool UK has recommended Imperial Brands. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Surely, the Rolls-Royce share price can’t go any higher in 2025?

The Rolls-Royce share price was the best performer on the FTSE 100 in 2023 and so far in 2024. Dr…

Read more »

A young woman sitting on a couch looking at a book in a quiet library space.
Investing Articles

Here’s how an investor could start buying shares with £100 in January

Our writer explains some of the things he thinks investors on a limited budget should consider before they start buying…

Read more »

Investing Articles

Forget FTSE 100 airlines! I think shares in this company offer better value to consider

Stephen Wright thinks value investors looking for shares to buy should include aircraft leasing company Aercap. But is now the…

Read more »

Investing Articles

Are Rolls-Royce shares undervalued heading into 2025?

As the new year approaches, Rolls-Royce shares are the top holding of a US fund recommended by Warren Buffett. But…

Read more »

Investing Articles

£20k in a high-interest savings account? It could be earning more passive income in stocks

Millions of us want a passive income, but a high-interest savings account might not be the best way to do…

Read more »

Investing Articles

3 tried and tested ways to earn passive income in 2025

Our writer examines the latest market trends and economic forecasts to uncover three great ways to earn passive income in…

Read more »

Investing Articles

Here’s what £10k invested in the FTSE 100 at the start of 2024 would be worth today

Last week's dip gives the wrong impression of the FTSE 100, which has had a pretty solid year once dividends…

Read more »

Investing Articles

UK REITs: a once-in-a-decade passive income opportunity?

As dividend yields hit 10-year highs, Stephen Wright thinks real estate investment trusts could be a great place to consider…

Read more »